Lila Sciences is developing an AI-enabled scientific superintelligence platform—paired with autonomous labs—that can run the entire scientific method. In a conversation with MobiHealthNews, Molly Gibson, president of future science at Lila Sciences, explained that this technology extends beyond traditional AI applications, such as protein modeling, by generating hypotheses, designing experiments and learning from results. She […]

ChatEHR, AI software developed at Stanford Medicine, is speeding up chart reviews by permitting clinicians to ask questions about medical records. Similar to how you can chat with a large language model like GPT-4, Stanford Health Care clinicians can connect with a patient’s medical record through ChatEHR.  In a statement, Stanford Medicine said the technology, currently

Manulife Canada, a financial services provider, is partnering with Maven Clinic, a virtual care clinic for women, to provide Manulife Group Benefits plan members access to Maven’s digital programs. Maven Clinic focuses on supporting women and families in areas such as fertility, family building and planning, maternity and newborn care, parenting, pediatrics and menopause. In

Goldeneye 1995 LLC, an affiliate of fintech investor and Ripple’s former chief risk officer, Greg Kidd, is buying a controlling interest in health monitoring company Know Labs using 1,000 Bitcoin and some extra cash.  U.S.-based medical device company Know Labs develops non-invasive health monitoring tools using radio-microwave spectroscopy to help identify and measure molecules inside

The FDA launched Elsa, a generative AI tool designed to help employees, including scientific reviewers and investigators, work more efficiently.  In a statement, the agency said the tool “modernizes agency functions and leverages AI capabilities to serve the American people better.” Constructed in a high-security government cloud environment, Elsa provides a platform for FDA employees to

Chronic care management company Omada Health will begin trading on the Nasdaq Global Market under the ticker symbol OMDA on June 6 at a public offering price of $19 per share, in the middle of its expected range.  The company will raise $150 million in its initial public offering.  Omada will offer 7.9 million shares

A game-based intervention developed by the University of New South Wales has shown potential as a drug-free treatment for chronic pain. HOW IT WORKS Called PainWaive, the neurofeedback intervention includes a kit with an EEG headset and a tablet preloaded with a game application.  The game app trains users to regulate abnormal brain activity associated

Direct-to-consumer virtual care company Hims & Hers Health announced it is acquiring telemedicine provider Zava, allowing it to expand into the UK and launch in Germany, France and Ireland. In a statement, the company said that the acquisition will “significantly strengthen Hims & Hers’ international footprint.” Currently, Zava’s medical team serves more than 1.3 million

U.S.-based General Catalyst is one of the largest venture capital firms globally, with a diverse portfolio of companies across various industries, including healthcare. Alexandre Momeni, a partner at General Catalyst focusing on AI infrastructure and health/bio, sat down with MobiHealthNews to discuss the investor’s perspective on funding emerging technologies, the risks associated with these investments and

Salvo Health, a digital gastrointestinal care company, raised $4 million in an extended Seed Prime round after announcing a $5 million investment in February of last year.  New investor, The Artemis Fund, participated in the extended round alongside existing investors City Light, Human Ventures, Threshold Ventures, Alumni Ventures, Felicis Ventures, and Torch Capital. “We launched